Further characterization of the predictive validity of the Brattleboro rat model for antipsychotic efficacy

Journal of Psychopharmacology

Volumn 25, Issue 6, 2011, Pages 836-841

  Feifel, D ^a   Shilling, P D ^a   Melendez, G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antipsychotic drugs; predictive validity; prepulse inhibition; schizophrenia

Indexed keywords

CHLORPROMAZINE; DIAZEPAM; IMIPRAMINE; SODIUM CHLORIDE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRATTLEBORO RAT; DRUG EFFECT; DRUG EFFICACY; FEMALE; MALE; NONHUMAN; PREDICTIVE VALIDITY; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; STARTLE REFLEX;

ANIMALS; ANTIPSYCHOTIC AGENTS; CHLORPROMAZINE; DIAZEPAM; DISEASE MODELS, ANIMAL; FEMALE; IMIPRAMINE; INHIBITION (PSYCHOLOGY); MALE; PSYCHOTROPIC DRUGS; RATS; RATS, BRATTLEBORO; SCHIZOPHRENIA; STARTLE REACTION; VALPROIC ACID;

EID: 79954520749     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881110388327     Document Type: Article

References (38)

1. Becker HC, Anton RF. Valproate potentiates and picrotoxin antagonizes the anxiolytic action of ethanol in a nonshock conflict task. Neuropharmacology. 1990 ; 29: 837-843 (Pubitemid 20276405)
2. Birkett SD, Pickering BT. The vasopressin precursor in the Brattleboro (di/di) rat. Int J Peptide Protein Res. 1988 ; 32: 565-572 (Pubitemid 19042062)
3. Bohus B, de Wied D. The vasopressin deficient Brattleboro rats: a natural knockout model used in the search for CNS effects of vasopressin. Prog Brain Res. 1998 ; 119: 555-573 (Pubitemid 29099995)
4. Cilia J, Gartlon JE, Shilliam C, Dawson LA, Moore SH, Jones DN. Further neurochemical and behavioural investigation of Brattleboro rats as a putative model of schizophrenia. J Psychopharmacol. 2010 ; 24: 407-419
5. Cilia J, Reavill C, Hagan JJ, Jones DN. Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats. Psychopharmacology (Berl). 2001 ; 156: 327-337 (Pubitemid 32702222)
6. de Jong TR, Snaphaan LJ, Pattij T, et al. Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats. Eur Neuropsychopharmacol. 2006 ; 16: 39-48 (Pubitemid 43005095)
7. Docherty NM, Gordinier SW. Immediate memory, attention and communication disturbances in schizophrenia patients and their relatives. Psychological Medicine. 1999 ; 29 (1). 189-197 (Pubitemid 29034536)
8. Duncan GE, Moy SS, Lieberman JA, Koller BH. Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function. Psychopharmacology (Berl). 2006 ; 184: 190-200 (Pubitemid 43083656)
9. Feifel D, Melendez G, Priebe K, Shilling PD. The effects of chronic administration of established and putative antipsychotics on natural prepulse inhibition deficits in Brattleboro rats. Behav Brain Res. 2007 ; 181: 278-286 (Pubitemid 46898666)
10. Feifel D, Melendez G, Shilling PD. Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effects. Neuropsychopharmacology. 2004 ; 29: 731-738 (Pubitemid 38402480)
11. Feifel D, Mexal S, Melendez G, Liu PY, Goldenberg JR, Shilling PD. The Brattleboro rat displays a natural deficit in social discrimination that is restored by clozapine and a neurotensin analog. Neuropsychopharmacology. 2009 ; 34: 2011-2018
12. Feifel D, Priebe K. Vasopressin-deficient rats exhibit sensorimotor gating deficits that are reversed by subchronic haloperidol. Biol Psychiatry. 2001 ; 50: 425-433 (Pubitemid 32885592)
13. Flood DG, Choinski M, Marino MJ, Gasior M. Mood stabilizers increase prepulse inhibition in DBA/2NCrl mice. Psychopharmacology (Berl). 2009 ; 205: 369-377
14. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl). 2001 ; 156: 117-154 (Pubitemid 32702206)
15. Geyer MA, Wilkinson LS, Humby T, Robbins TW. Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biol Psych. 1993 ; 34: 361-372 (Pubitemid 23295752)
16. Hammer TB, Oranje B, Glenthoj BY. The effects of imipramine on P50 suppression, prepulse inhibition and habituation of the startle response in humans. Int J Neuropsychopharmacol. 2007 ; 10: 787-795 (Pubitemid 350035826)
17. Kestler LP, Walker E, Vega EM. Dopamine receptors in the brains of schizophrenia patients: a meta-analysis of the findings. Behav Pharmacol. 2001 ; 12: 355-371 (Pubitemid 32983509)
18. Kumari V, Sharma T. Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research. Psychopharmacology (Berl). 2002 ; 162: 97-101 (Pubitemid 34743949)
19. Le Pen G, Moreau JL. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology. 2002 ; 27: 1-11 (Pubitemid 34626738)
20. Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology. 1995 ; 122: 35-43
21. Malla AK. Negative symptoms and affective disturbance in schizophrenia and related disorders. Can J Psych Rev Can Psych. 1995 ; 40 (7 Suppl 2). S55 - S59
22. Mansbach RS. Effects of NMDA receptor ligands on sensorimotor gating in the rat. Eur J Pharmacol. 1991 ; 202: 61-66
23. Mansbach RS, Geyer MA, Braff DL. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology. 1988 ; 94: 507-514 (Pubitemid 18087401)
24. Ong JC, Brody SA, Large CH, Geyer MA. An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition. J Pharmacol Exp Ther. 2005 ; 315: 1163-1171 (Pubitemid 41635404)
25. Oranje B, Kahn RS, Kemner C, Verbaten MN. Modulating sensorimotor gating in healthy volunteers: the effects of desipramine and haloperidol. Psychiatry Res. 2004 ; 127: 195-205 (Pubitemid 39024497)
26. Ouagazzal AM, Jenck F, Moreau JL. Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?. Psychopharmacology (Berl). 2001 ; 156: 273-283 (Pubitemid 32702218)
27. Phillips ML, David AS. Facial processing in schizophrenia and delusional misidentification: cognitive neuropsychiatric approaches. Schizophrenia Research. 1995 ; 17: 109-114
28. Pouzet B, Andersen MP, Hogg S. Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats. Psychopharmacology (Berl). 2005 ; 178: 9-16 (Pubitemid 40298686)
29. Rigdon GC, Viik K. Prepulse inhibition as a screening test for potential antipsychotics. Drug Dev Res. 1991 ; 23: 91-99
30. Roche M, Shanahan E, Harkin A, Kelly JP. Trans-species assessment of antidepressant activity in a rodent model of depression. Pharmacol Rep. 2008 ; 60: 404-408
31. Shilling PD, Kinkead B, Murray T, Melendez G, Nemeroff CB, Feifel D. Upregulation of striatal dopamine-2 receptors in Brattleboro rats with prepulse inhibition deficits. Biol Psychiatry. 2006 ; 60: 1278-1281 (Pubitemid 44693532)
32. Sipes TA, Geyer MA. Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology. 1994 ; 33: 441-448 (Pubitemid 24168715)
33. Swerdlow NR, Geyer MA. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull. 1998 ; 24: 285-301 (Pubitemid 28404986)
34. Umeda K, Suemaru K, Todo N, et al. Effects of mood stabilizers on the disruption of prepulse inhibition induced by apomorphine or dizocilpine in mice. Eur J Pharmacol. 2006 ; 553: 157-162 (Pubitemid 44779598)
35. Varty GB, Higgins GA. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology. 1995 ; 122: 15-26
36. Weiss IC, Feldon J, Domeney AM. Circadian time does not modify the prepulse inhibition response or its attenuation by apomorphine. Pharmacol Biochem Behav. 1999 ; 64: 501-505 (Pubitemid 29488476)
37. Williams AR, Carey RJ, Miller M. Behavioral differences between vasopressin-deficient (Brattleboro) and normal Long-Evans rats. Peptides. 1983 ; 4: 711-716 (Pubitemid 14223718)
38. Yamada S, Harano M, Annoh N, Nakamura K, Tanaka M. Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats. Biol Psych. 1999 ; 46: 832-838 (Pubitemid 29460911)